Search Results

Ginkgo Bioworks, which is building the leading platform for cell programming and biosecurity, announced the acquisition of AgBiome’s platform assets, including over 115,000 fully sequenced and isolated strains, over 500 million unique gene sequences, and relevant functional data and metadata, as well as AgBiome’s development pipeline.

AgBiome®, Inc. and Ginkgo Bioworks announced a partnership to optimize the performance of products in AgBiome’s pipeline of agricultural biologicals.

AgBiome, a leader in developing innovative products from the Earth’s microbial communities, today announced Krysta Harden and Alison Lawton have joined AgBiome’s Board of Directors.

AgBiome, a leader in developing innovative products from the Earth’s microbial communities, announced Dr. Marijn Dekkers as the company’s Chairman, effective January 1, 2021.

AgBiome®, a leader in developing innovative products from the Earth’s microbial communities, announced a recent patent directed toward the Connate™ product line granted in the United States, further strengthening AgBiome’s IP Protection around novel product offerings

AgBiome®, a leader in developing innovative products from the Earth’s microbial communities, has announced the submission of Theia™ fungicide, its next product, to the EPA for review.

Genective, a joint venture between Limagrain and KWS, dedicated to the development of transgenic traits, and AgBiome, a leader in the discovery and development of new technology from microbes, announced today a strategic partnership to accelerate commercialization of coleopteran and lepidopteran resistant transgenic traits with unique modes of action

- Highly innovative genome editing technology platform accelerates and broadens ElevateBio’s cell and gene therapy enabling technologies - LifeEDIT Therapeutics to develop its own pipeline of potentially life-transforming therapeutics - LifeEDIT Therapeutics to leverage its novel gene editing platform with strategic partners including ElevateBio portfolio companies

Collaboration furthers Elanco’s commitment to antibiotic stewardship and offering alternatives to pork producers’ most difficult challenges

ElevateBio, LLC, a cell and gene therapy technology company focused on powering transformative cell and gene therapies, announced that it has acquired all of AgBiome Delta, LLC’s shares of Life Edit Therapeutics, Inc. Life Edit offers a powerful suite of gene editing technologies that have the potential for any genomic sequence of interest to be removed, added, or altered.